摘要
随着现代诊疗技术的提高,大剂量化疗和靶向药物的应用,淋巴瘤的生存期延长;同时反复化疗后继发的治疗相关性急性髓系白血病(AML)/骨髓增生异常综合征(MDS)发生率也不断上升,并成为非霍奇金淋巴瘤(NHL)预后不良的远期并发症之一。
A diffuse large B-cell lymphoma patient after 7cycles treatment of CHOP combined with thrombocytopenia,coagulation abnormalities was diagnosed APL after bone marrow cytology,pathology,chromosome,gene fusion.The previous treatment and chemotherapy constituted of tretinoin,daunorubicin,cytarabine and arsenic trioxide induced differentiation invalided,the patient deteriorated rapidly and died.
出处
《临床血液学杂志》
CAS
2015年第1期72-74,共3页
Journal of Clinical Hematology